Characterization of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs

AIDS Research and Human Retroviruses

Volumn 21, Issue 11, 2005, Pages 971-976

  Ly, Nary ^a   Recordon Pinson, Patricia ^b   Phoung, Viseth ^a   Srey, Chanthan ^a   Kruy, Leang Sim ^c   Koum, Kanal ^d   Chhum, Vannarith ^e   Glaziou, Philippe ^a   Fleury, Herve J ^b   Reynes, Jean Marc ^a  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b University Victor Segalen   (France)

^c Hopital Calmette   (Cambodia)

^d National Maternal and Child Health Center   (Cambodia)

^e Provincial Health Department   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ARGININE; ASPARAGINE; ASPARTIC ACID; GLUTAMIC ACID; HISTIDINE; ISOLEUCINE; LYSINE; METHIONINE; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VALINE;

ARTICLE; CAMBODIA; DRUG SENSITIVITY; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; PRIORITY JOURNAL; SEROCONVERSION; UNINDEXED SEQUENCE; VIRUS ENVELOPE; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CAMBODIA; DRUG RESISTANCE, VIRAL; FEMALE; GENES, ENV; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECOMBINATION, GENETIC; RESEARCH SUPPORT, NON-U.S. GOV'T; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA;

EID: 28944436528     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.971     Document Type: Article

References (14)

1. Peeters M, Toure-Kane C, and Nkengasong JN: Genetic diversity of HIV in Africa: Impact on diagnosis, treatment, vaccine development and trials. AIDS 2003;17:2547-2560.
2. Kantor R and Katzenstein D: Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev 2003;5:25-35.
3. Auswinporn S, Jenwitheesuk E, Vibhagool A, et al.: Genotypic subtyping of the HIV-1 polymerase gene in 30 naive patients from Thailand. Southeast Asian J Trop Med Public Health 2001;32:346-350.
4. Hsu LY, Subramaniam R, Bacheler L, and Paton NI: Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore. J Acquir Immune Defic Syndr 2005;38:5-13.
5. Lan NT, Recordon-Pinson P, Hung PV, et al.: HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRFO1_AE and presence of major resistance mutations to antiretroviral drugs. AIDS Res Hum Retroviruses 2003;19-925-928.
6. Sirivichayakul S, Chantratita W, Sutthent R, et al.: Survey of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRFO1_AE in Thailand from 1990 to 2000. AIDS Res Hum Retroviruses 2001;17:1077-1081.
7. Kusagawa S, Sato H, Kato K, et al.: HIV type 1 env subtype E in Cambodia. AIDS Res Hum Retroviruses 1999;15:91-94.
8. Menu E, Reynes JM, Muller-Trutwin MC, et al.: Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:481-487.
9. Toni TD, Recordon-Pinson P, Minga A, et al: Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Cote d'Ivoire: ANRS 1257 study. AIDS Res Hum Retroviruses 2003;19:713-717.
10. Sirivichayakul S, Ruxrungtham K, Ungsedhapand C, et al.: Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors. AIDS 2003;17:1889-1896.
11. Tovanabutra S, Robison V, Wongtrakul J, et al.: Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J Acquir Immune Defic Syndr 2002;29:275-283.
12. Ariyoshi K, Matsuda M, Miura H, et al.: Patterns of point mutations associated with antiretroviral drag treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection. J Acquir Immune Defic Syndr 2003;33:336-342.
13. Hachiya A, Gatanaga H, Kodama E, et al: Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naive patients. Virology 2004;327:215-224.
14. Johnson VA, Bran-Vezinet F, Clotet B, et al: Update of the drag resistance mutations in HIV-1: 2004. Top HIV Med 2004;12:119-124.